Is massive scale proteomics causing a paradigm shift in biomarker discovery?

ABSTRACT

In this 45-minute talk, Dr. Stefánsson will discuss the largest population proteomics study ever performed to help provide more insight on disease and health outcomes. This collaborative research assembled expertise from deCODE Genetics and SomaLogic to combine the study of genetic and protein diversity to characterize disease biomarkers in the human population. The data from this type of proteomic study will inform drug discovery and development as well as improvements in health management. You will learn about:

  • The high-throughput technologies that made this study possible
  • The application of population proteomics in diagnosis and management of common and rare diseases

Kari-Stefansson-Headshot-Hex

Dr. Kári Stefánsson

CEO, deCode Genetics

Kári Stefánsson is an Icelandic neurologist and founder and CEO of Reykjavik-based biopharmaceutical company deCODE genetics. In Iceland he has pioneered the use of population-scale genetics to understand variation in the sequence of the human genome.


Share with colleagues

More webinars

WebinarAccelerating precision medicine of cancer with SomaScan® proteomics

Proteomics has emerged as the next frontier in precision medicine, and several innovative proteomics platforms have been developed to drive biomarker discovery. We [at Beth Israel Deaconess Medical Center] are using the currently most comprehensive proteomics technology -- the SomaScan Platform, which measures 7,000 proteins -- to discover and independently validate diagnostic, predictive, and prognostic biomarkers for various cancers.

Learn more

WebinarImproving clinical development productivity with high-plex proteomics

While the vast majority of approved pharmaceuticals target proteins, knowledge of the full complement of proteins that are acted on by drugs, or are potentially druggable, remains incomplete. Assessment of the human proteome is thus increasingly recognized as a priority for successful and cost-effective drug development and clinical research.

Learn more

WebinarMillions for Proteomics Research in the Peer Reviewed Medical Research Program

How SomaLogic Technologies can give your research programs an edge

Learn more